TY  - JOUR

T1  - A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer

JO  - British Journal of Cancer

PY  - 2004/08/01

AU  - Hussain SA

AU  - Stocken DD

AU  - Riley P

AU  - Palmer DH

AU  - Peake DR

AU  - Geh JI

AU  - Spooner D

AU  - James ND

ED  - 

DO  - DOI: 10.1038/sj.bjc.6602112

PB  - Springer Science and Business Media LLC

VL  - 91

IS  - 5

SP  - 844

EP  - 849

Y2  - 2024/12/22

ER  -